Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01219283 · ClinicalTrials.gov registry record

Study of the Efficacy of 24 Chromosome Preimplantation Genetic Diagnosis (PGD)

A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
334
Enrollment target

NCT01219283 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 334 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01219283 has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
334 participants
Enrollment target

Study Summary

The purpose of this study is to determine if 24 chromosome preimplantation genetic diagnosis (PGD) increases implantation and delivery rates in couples attempting to conceive through in vitro fertilization (IVF).

Trial Details

FieldValue
Enrollment Target 334 participants
Start Date 2009-08
Est. Completion 2013-06

What the Registry Record Tells You About NCT01219283

The ClinicalTrials.gov registry entry for NCT01219283 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01219283 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01219283 about?

NCT01219283 is a clinical study titled "Study of the Efficacy of 24 Chromosome Preimplantation Genetic Diagnosis (PGD)". The purpose of this study is to determine if 24 chromosome preimplantation genetic diagnosis (PGD) increases implantation and delivery rates in couples attempting to conceive through in vitro fertilization (IVF).

What is the current status of trial NCT01219283?

This trial is currently completed. The enrollment target is 334 participants. The study started on 2009-08. Estimated completion is 2013-06.

Who is sponsoring clinical trial NCT01219283?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.